Search results for "Hamilton Rating Scale for Depression"

showing 5 items of 15 documents

The association between burning mouth syndrome and sleep disturbance: A case-control multicentre study

2018

Objectives: To investigate the quality of sleep and the psychological profiles of a large cohort of Italian patients with burning mouth syndrome (BMS) and to clarify the relationships between these variables and pain. Methods: In this case–control study, 200 patients with BMS vs an equal number of age- and sex-matched healthy controls, recruited in 10 universities, were enrolled. The Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating Scale for Anxiety (HAM-A), Numeric Pain Intensity Scale (NRS) and Total Pain Rating Index (T-PRI) were administered. Descriptive statistics, including the Mann–Whitney U test and …

MaleAnxietyinsomnia symptomsPittsburgh Sleep Quality Indexanxiety burning insomnia symptoms mood disorders pain sleep0302 clinical medicinePrevalenceSleep Wake DisorderpainburningSleep disorderDepressionEpworth Sleepiness ScaleOtorhinolaryngology2734 Pathology and Forensic MedicineBurning mouth syndromeMiddle Agedanxietymood disordershumanitiesAnxietyFemalemedicine.symptomCase-Control StudieHumanAdultSleep Wake Disordersmedicine.medical_specialtyanxiety; burning; insomnia symptoms; mood disorders; pain; sleep; Otorhinolaryngology2734 Pathology and Forensic Medicine; Dentistry (all)anxiety; burning; insomnia symptoms; mood disorders; pain; sleepPainmood disorderBurning Mouth SyndromeSettore MED/28 - MALATTIE ODONTOSTOMATOLOGICHE03 medical and health sciencesRating scaleinsomnia symptommedicineHumanssleepGeneral DentistryAgedbusiness.industryHamilton Rating Scale for Depression030206 dentistrymedicine.diseaseMoodOtorhinolaryngologyCase-Control StudiesDentistry (all)Physical therapybusinessSleep030217 neurology & neurosurgery
researchProduct

Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up

2007

Abstract Objective Many studies have reported that cognitive ability may be predictive of the functional outcome for patients with schizophrenia. However, no study has prospectively examined these aspects in schizophrenia and bipolar disorders simultaneously. The present study attempted to analyze if neurocognition and clinical status predicts the real-life functioning for patients with schizophrenia or bipolar I disorder, using a longitudinal design. Method Forty-seven schizophrenic and 43 bipolar I outpatients were assessed twice with a neurocognitive battery (Executive Functions, Working Memory, Verbal Memory, Visual Memory, Visual-Motor Processing, Vigilance, Vocabulary and Motor Speed …

Malemedicine.medical_specialtyBipolar DisorderBipolar I disorderGlobal Assessment of FunctioningSeverity of Illness IndexDisability EvaluationYoung AdultPredictive Value of Testsmental disordersmedicineHumansProspective StudiesBipolar disorderPsychiatryDemographyWechsler ScalesNeuropsychologyHamilton Rating Scale for Depressionmedicine.diseaseDiagnostic and Statistical Manual of Mental DisordersPsychiatry and Mental healthClinical PsychologySchizophreniaFemaleVerbal memorymedicine.symptomCognition DisordersPsychologyNeurocognitiveManiaFollow-Up StudiesJournal of Affective Disorders
researchProduct

Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial

2014

Background: The integrated treatment of first episode psychosis has been shown to improve functionality and negative symptoms in previous studies. In this paper, we describe a study of integrated treatment (individual psychoeducation complementary to pharmacotherapy) versus treatment as usual, comparing results at baseline with those at 6-month re-assessment (at the end of the study) for these patients, and online training of professionals to provide this complementary treatment, with the following objectives: 1) to compare the efficacy of individual psychoeducation as add-on treatment versus treatment as usual in improving psychotic and mood symptoms; 2) to compare adherence to medication,…

Time Factorsmedicine.medical_treatmentGlobal Assessment of FunctioningMedicine (miscellaneous)Liebowitz social anxiety scaleWeb-based instructionlaw.inventionStudy Protocolmulticenter trialClinical ProtocolsRandomized controlled triallawSurveys and QuestionnairesSingle-Blind MethodPharmacology (medical)PHARMACOLOGY (MEDICAL)validationPositive and Negative Syndrome ScaleCombined Modality TherapyTreatment OutcomeResearch Designspanish versionAprenentatge electrònicAnxietymedicine.symptomAntipsychotic Agentsmedicine.medical_specialtyPsicosiMedication Adherencescale1st-episode psychosisPredictive Value of TestsPsychoeducationmedicineHumansSocial BehaviorPsychiatryPsychiatric Status Rating ScalesInternetbusiness.industryMEDICINEBrain-Derived Neurotrophic FactorHamilton Rating Scale for DepressionPsychoses5-year follow-upstandard treatementPsychotherapyAffectLogistic ModelsMoodPsychotic Disordersopus trialSpainquality-of-lifeLinear ModelsQuality of Lifebusinesscognitive-behavior therapyBiomarkersComputer-Assisted InstructionTrials
researchProduct

Neurocognitive impairment and psychosocial functioning in bipolar II disorder

2011

Sole B, Bonnin CM, Torrent C, Balanza-Martinez V, Tabares-Seisdedos R, Popovic D, Martinez-Aran A, Vieta E. Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Objective:  There is a growing body of evidence on neurocognitive impairment in euthymic bipolar patients, but this issue has been studied mostly in bipolar I disorder, data on bipolar II (BD-II) are scant and discrepant. The two aims of this study were to ascertain whether strictly defined euthymic BD-II patients would present neurocognitive disturbances and to evaluate their impact on functional outcome. Method:  Forty-three BD-II patients and 42 demographically and educationally matched healthy subjects …

medicine.medical_specialtyBipolar I disorderTrail Making TestHamilton Rating Scale for DepressionVerbal learningmedicine.diseaseYoung Mania Rating ScalePsychiatry and Mental healthBipolar II disorderHypomaniamedicinemedicine.symptomPsychologyPsychiatryNeurocognitiveActa Psychiatrica Scandinavica
researchProduct

No relationship between baseline salivary alpha-amylase and State-Trait Anxiety Inventory Score in drug-naïve patients with short-illness-duration fi…

2016

BACKGROUND Salivary α-amylase (sAA) activity alternations are observed in major depressive disorder (MDD) being associated with depression severity and its specific psychopathological dimensions with anxiety being attributed to distress. No data is available on sAA in MDD according to Hamilton Rating Scale for Depression (HAMD-17) and State-Trait Anxiety Inventory (STAI). The exploratory study examines whether and to what extent baseline sAA level is interrelated to the psychopathological features including severity of symptoms and specific psychopathological dimensions. MATERIAL AND METHODS The basal, non-stimulated sAA activity was studied in 20 non-late-life adult, treatment-naive MDD pa…

medicine.medical_specialtybehavioral disciplines and activities03 medical and health sciences0302 clinical medicinemental disordersmedicinePsychiatryGeneral DentistryFirst episodebusiness.industryResearchHamilton Rating Scale for Depressionmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Community and Preventive Dentistry030227 psychiatryDrug-naïveDistressstomatognathic diseasesUNESCO::CIENCIAS MÉDICASMajor depressive disorderAnxietymedicine.symptombusiness030217 neurology & neurosurgeryState-Trait Anxiety Inventorymedicine.drugPsychopathologyJournal of clinical and experimental dentistry
researchProduct